[go: up one dir, main page]

GB201611276D0 - Taste masked liquid pharmaceutical composition of (RS)-4-(ethyl[1-(4-methoxyphenyl)propan-2-yl]am ino)butyl 3, 4-dimethoxybenzoate - Google Patents

Taste masked liquid pharmaceutical composition of (RS)-4-(ethyl[1-(4-methoxyphenyl)propan-2-yl]am ino)butyl 3, 4-dimethoxybenzoate

Info

Publication number
GB201611276D0
GB201611276D0 GBGB1611276.5A GB201611276A GB201611276D0 GB 201611276 D0 GB201611276 D0 GB 201611276D0 GB 201611276 A GB201611276 A GB 201611276A GB 201611276 D0 GB201611276 D0 GB 201611276D0
Authority
GB
United Kingdom
Prior art keywords
dimethoxybenzoate
ino
propan
methoxyphenyl
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1611276.5A
Other versions
GB2551971A (en
GB2551971B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syri Ltd
Original Assignee
Syri Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syri Ltd filed Critical Syri Ltd
Priority to GB1611276.5A priority Critical patent/GB2551971B/en
Publication of GB201611276D0 publication Critical patent/GB201611276D0/en
Priority to PCT/IB2017/052768 priority patent/WO2018002738A1/en
Publication of GB2551971A publication Critical patent/GB2551971A/en
Application granted granted Critical
Publication of GB2551971B publication Critical patent/GB2551971B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
GB1611276.5A 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof Active GB2551971B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1611276.5A GB2551971B (en) 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof
PCT/IB2017/052768 WO2018002738A1 (en) 2016-06-29 2017-05-11 Taste masked liquid pharmaceutical composition of (rs)-4-(ethyl[1-(4-methoxyphenyl)propan-2-yl]amino)butyl 3,4-dimethoxybenzoate or pharmaceutically acceptable salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1611276.5A GB2551971B (en) 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof

Publications (3)

Publication Number Publication Date
GB201611276D0 true GB201611276D0 (en) 2016-08-10
GB2551971A GB2551971A (en) 2018-01-10
GB2551971B GB2551971B (en) 2020-09-16

Family

ID=56891716

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1611276.5A Active GB2551971B (en) 2016-06-29 2016-06-29 Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof

Country Status (2)

Country Link
GB (1) GB2551971B (en)
WO (1) WO2018002738A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928609A (en) * 1973-04-05 1975-12-23 Dooner Lab Non-alcoholic theophylline product
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
JP2004535370A (en) * 2001-03-05 2004-11-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Liquid pharmaceutical composition with masked taste
EP1411955A4 (en) * 2001-07-31 2006-07-05 Wyeth Corp Sucralose formulations to mask unpleasant tastes
BRPI0714882A2 (en) * 2006-07-21 2013-05-21 Lyne Lab Calcium acetate liquid composition and use of an aqueous solution comprising from about 7% (w / v) to about 21% (w / v) calcium acetate
EP2926810A1 (en) * 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen

Also Published As

Publication number Publication date
GB2551971A (en) 2018-01-10
GB2551971B (en) 2020-09-16
WO2018002738A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
SG11202005962YA (en) Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
EP3357513A4 (en) Pharmaceutical composition and application thereof
EP3284738A4 (en) 5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof
IL271807A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
AU201816675S (en) Drip chamber and spike assembly for medical lines
ZA201901717B (en) Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof
EP3279207A4 (en) Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof
PL3323413T3 (en) Pharmaceutical composition containing celecoxib and tramadol
EP3639677A4 (en) Ingredient-containing liquid seasoning
EP3275455A4 (en) Pharmaceutical composition containing silybin and l-carnitine
IL273339A (en) Griseofulvin compound and pharmaceutical use thereof
ZA202004311B (en) Pyrazole amide compound and application thereof, and fungicide
EP3670500A4 (en) Chemical compound, pharmaceutical composition thereof, and use and application thereof
EP3324757A4 (en) Allergy preventing dosage controlled food packets
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
GB2564444B (en) Liquid pharmaceutical composition of flecainide
EP3539957A4 (en) 3,4-bipyridyl pyrazole derivative, and preparation method therefor and medical application thereof
SG11201807498TA (en) Flavor modulator containing 4-alkoxycinnamaldehyde derivative as active ingredient
IL267136A (en) Pharmaceutical composition containing celecoxib
EP3338771A4 (en) Pharmaceutical composition of a combination of tramadol-etoricoxib hydrochloride for the treatment of pain
IL276410A (en) Pyrazole compounds and preparation thereof
PL3176164T3 (en) Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
GB201611276D0 (en) Taste masked liquid pharmaceutical composition of (RS)-4-(ethyl[1-(4-methoxyphenyl)propan-2-yl]am ino)butyl 3, 4-dimethoxybenzoate
EP3253379A4 (en) Pharmaceutical composition for the treatment of obesity
ZA202003079B (en) Pharmaceutical compositions comprising safinamide

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20230629

S28 Restoration of ceased patents (sect. 28/pat. act 1977)

Free format text: APPLICATION FILED

S28 Restoration of ceased patents (sect. 28/pat. act 1977)

Free format text: RESTORATION ALLOWED

Effective date: 20240423